Studies have demonstrated that overexpression of TIP30 can restore the sensitivity of non-small cell lung cancer cells to gefitinib by attenuating both cytoplasmic and nuclear EGFR signaling pathways [61]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.